< 生产厂家价格 >

4,6-二氯-5-氨基嘧啶

4,6-二氯-5-氨基嘧啶用途

【用途一】
用于医药中间体的合成

点击显示

4,6-二氯-5-氨基嘧啶名称

[ CAS 号 ]:
5413-85-4

[ 中文名 ]:
4,6-二氯-5-氨基嘧啶

[ 英文名 ]:
4,6-Dichloro-5-pyrimidinamine

[中文别名 ]:

5-氨基-4,6-二氯嘧啶

[英文别名 ]:

4,6-dichloro-5-pyrimidinamin
5-AMINO-4,6-DICHLOROPYFIMIDINE
Pyrimidine, 5-amino-4,6-dichloro-
5-Amino-4,6-dichloro
5-Pyrimidinamine, 4,6-dichloro-
4,6-Dichloro-5-aminopyrimidine
5-Amino-4,6-dichloropyrimidine
4,6-Dichloro-5-pyrimidinamine
4,6-dichloropyrimidin-5-amine
5-AMino-4

4,6-二氯-5-氨基嘧啶生物活性

[ 描述 ]:

4,6-二氯嘧啶-5-胺是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

信号通路 >> 其他 >> 其他

4,6-二氯-5-氨基嘧啶物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
267.1±35.0 °C at 760 mmHg

[ 熔点 ]:
145-148 °C(lit.)

[ 分子式 ]:
C₄H₃Cl₂N₃

[ 分子量 ]:
163.99

[ 闪点 ]:
115.3±25.9 °C

[ 精确质量 ]:
162.970398

[ PSA ]:
51.80000

[ LogP ]:
1.81

[ 外观性状 ]:
稻黄色固体

[ 蒸汽压 ]:
0.0±0.5 mmHg at 25°C

[ 折射率 ]:
1.633

[ 储存条件 ]:
2-8°C

[ 水溶解性 ]:
slightly soluble

4,6-二氯-5-氨基嘧啶MSDS

4,6-二氯-5-氨基嘧啶安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi: Irritant;

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36-S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
29335995

4,6-二氯-5-氨基嘧啶合成路线

4,6-二氯-5-氨基嘧啶上下游产品

4,6-二氯-5-氨基嘧啶上游产品

4,6-二氯-5-氨基嘧啶下游产品

4,6-二氯-5-氨基嘧啶海关

[ 海关编码 ]: 2933599090

[ 中文概述 ]:
2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4,6-二氯-5-氨基嘧啶文献

6-(Alkylamino)-9-benzyl-9H-purines. A new class of anticonvulsant agents.

J. Med. Chem. 31(3) , 606-12, (1988)

Several 9-alkyl-6-substituted-purines were synthesized and tested for anticonvulsant activity against maximal electroshock-induced seizures (MES) in rats. Most compounds were prepared in three steps f...

An efficient and regiospecific strategy to N7-substituted purines and its application to a library of trisubstituted purines.

J. Comb. Chem. 8(3) , 410-6, (2006)

A regiospecific strategy for the preparation of N(7)-substituted purines in an efficient manner was devised. This approach to 6,7,8-trisubstituted purines relies on the cyclization reactions of suitab...

Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.

J. Med. Chem. 35(22) , 4180-4, (1992)

The synthesis of various chiral derivatives of (+)-erythro-9-(2-hydroxy-3-nonyl)adenine, (+)-EHNA, from (2S,3R)-3-amino-1,2-O-isopropylidene-1,2-nonanediol by condensation with 5-amino-4,6-dichloropyr...

更多文献